Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001664710-17-000002
Filing Date
2017-11-13
Accepted
2017-11-13 13:54:49
Documents
1
Effectiveness Date
2017-11-13
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8372
  Complete submission text file 0001664710-17-000002.txt   9510
Mailing Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421 617-513-8774
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-262318 | Film No.: 171195097